Cyxone presenterar en uppdaterad plan för Rabeximod 15 oktober, 2020 Bioteknikbolaget Cyxone meddelade nyligen en uppdaterad plan för utvecklingen av sin läkemedelskandidat Rabeximod. De fyra nya patentansökningar som skickades in tidigare i år kommer att bidra till en avsevärd ... LÄS MER!
Coronavirus update: living in limbo as new treatments are being tested 8 april, 2020 Since being declared a pandemic by the World Health Organization last month, Covid-19 cases have spiked to almost 1.5 million and the number of fatalities has seen a 20-fold increase. Now, many of the countries... LÄS MER!
BioStock’s article series on autoimmune disease: Finding the Common Denominator 8 juli, 2019 BioStock’s article series on autoimmune disease has so far focused on two of the most common autoimmune disorders: rheumatoid arthritis and multiple sclerosis. However, there are more than 80 other autoimmune d... LÄS MER!
BioStock’s article series on autoimmune disease: Drug Development for RA and MS 4 juli, 2019 *Updated November 14, 2019 Therapies for autoimmune diseases are available but do not work for all patients, and when they do, side effects can be severe. There is a strong need for new therapies and therefo... LÄS MER!
BioStock’s article series on autoimmune disease: The Science 2 juli, 2019 Little is known about the exact causes of autoimmune disease. The diverse array of such diseases creates an impasse for researchers who struggle to find a common denominator that could lead to better treatments... LÄS MER!
BioStock’s article series on autoimmune disease: The Patients 27 juni, 2019 Autoimmune diseases are on the rise, and no one has a clear answer as to why. More than 100 autoimmune disorders have been documented, and most burden patients with chronic pain and other debilitating symptoms ... LÄS MER!
